Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life

Show full item record



Permalink

http://hdl.handle.net/10138/266774

Citation

BMC Pulmonary Medicine. 2018 Nov 20;18(1):172

Title: Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life
Author: Rajala, K.; Lehto, J. T; Sutinen, E.; Kautiainen, H.; Myllärniemi, M.; Saarto, T.
Publisher: BioMed Central
Date: 2018-11-20
URI: http://hdl.handle.net/10138/266774
Abstract: Abstract Background Idiopathic pulmonary fibrosis (IPF) is a chronic disease with a high symptom burden and poor survival that influences patients’ health-related quality of life (HRQOL). We aimed to evaluate IPF patients’ symptoms and HRQOL in a well-documented clinical cohort during their last two years of life. Methods In April 2015, we sent the Modified Medical Research Council Dyspnea Scale (MMRC), the modified Edmonton Symptom Assessment Scale (ESAS) and a self-rating HRQOL questionnaire (RAND-36) to 300 IPF patients, of which 247 (82%) responded. Thereafter, follow-up questionnaires were sent every six months for two years. Results Ninety-two patients died by August 2017. Among these patients, HRQOL was found to be considerably low already two years before death. The most prominent declines in HRQOL occurred in physical function, vitality, emotional role and social functioning (p < 0.001). The proportion of patients with MMRC scores ≥3 increased near death. Breathlessness and fatigue were the most severe symptoms. Symptom severity for the following symptoms increased significantly and reached the highest mean scores during the last six months of life (numeric rating scale/standard deviation): breathlessness (7.1/2.8), tiredness (7.0/2.3), dry mouth (6.0/3.0), cough (5.8/2.9), and pain with movement (5.0/3.5). Conclusions To our knowledge this is the first study demonstrating, that IPF patients experience remarkably low HRQOL already two years before death, especially regarding physical role. In addition, they suffer from severe breathlessness and fatigue. Furthermore, physical, social and emotional wellbeing deteriorate, and symptom burden increases near death. Regular symptom and HRQOL measurements are essential to assess palliative care needs in patients with IPF.
Subject: Idiopathic pulmonary fibrosis
Palliative care
Health related quality of life
Symptoms


Files in this item

Total number of downloads: Loading...

Files Size Format View
12890_2018_Article_738.pdf 1.437Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record